Tilray Brands, Inc.
TLRYNasdaq
$4.30
↓ -1.1%Jul 17 close · end-of-day
Price
1Y↓ -28.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$484.5M
Enterprise Value
$273.4M
P/E
0.7
P/S
0.6
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$858.3M
Net Income (TTM)
-$1.3B
Free Cash Flow (TTM)
—
Gross Margin
27.7%
Operating Margin
-173.7%
Net Margin
-156.7%
ROE
-86.3%
ROIC
-87.5%
Debt / Equity
0.0
Net Cash
$211.1M
Return 1Y
-29.7%
Company profile
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company operates Tilray Medical, which provides GMP-certified flowers, oils, vapes, edibles, and topicals.
- CEO
- Irwin D. Simon
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 1,700
- Headquarters
- New York
- Website
- tilray.com
Earnings
TLRY Q3 2026 Earnings
Period ends 2026-02-28
MetricActualYoY
Revenue$206.7M↑ +11.3%
Diluted EPS-$0.24↓ -97.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $210.5M | $513.1M | $628.4M | $627.1M | $788.9M | $821.3M |
| Gross profit | $24.7M | $123.2M | $116.8M | $147.0M | $223.4M | $240.6M |
| Operating income | -$201.1M | -$132.2M | -$610.4M | -$1.4B | -$174.7M | -$2.3B |
| Net income | -$271.1M | -$367.4M | -$476.8M | -$1.5B | -$245.0M | -$2.2B |
| Diluted EPS | — | -$1.36 | -$0.99 | -$2.35 | -$0.33 | -$2.46 |
| Operating cash flow | -$129.4M | -$44.7M | -$177.3M | $7.9M | -$30.9M | -$94.6M |
| Free cash flow | -$174.0M | — | — | — | — | — |
| Gross margin | 11.7% | 24.0% | 18.6% | 23.4% | 28.3% | 29.3% |
| Operating margin | -95.6% | -25.8% | -97.1% | -218.4% | -22.1% | -277.9% |
| Net margin | -128.8% | -71.6% | -75.9% | -231.6% | -31.1% | -266.3% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $229.9M | $200.0M | $210.9M | $185.8M | $224.5M | $209.5M | $217.5M | $206.7M |
| Gross profit | $82.3M | $59.7M | $61.2M | $52.0M | $67.6M | $57.5M | $57.5M | $55.0M |
| Operating income | -$16.5M | -$36.6M | -$42.2M | -$759.9M | -$1.4B | $2.1M | -$22.3M | -$26.4M |
| Net income | -$31.7M | -$39.2M | -$85.3M | -$789.4M | -$1.3B | -$322,000.00 | -$44.9M | -$26.6M |
| Diluted EPS | -$0.04 | -$0.04 | -$0.99 | -$8.69 | $7.26 | $0.00 | -$0.41 | -$0.24 |
| Operating cash flow | $30.7M | -$35.3M | -$40.7M | -$5.8M | -$12.8M | -$1.3M | -$8.5M | -$21.9M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 35.8% | 29.8% | 29.0% | 28.0% | 30.1% | 27.4% | 26.4% | 26.6% |
| Operating margin | -7.2% | -18.3% | -20.0% | -409.0% | -643.1% | 1.0% | -10.2% | -12.8% |
| Net margin | -13.8% | -19.6% | -40.5% | -424.9% | -566.9% | -0.2% | -20.7% | -12.9% |
Company news
Jul 17, 2026
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.